Royal Bank of Canada reissued their sector perform rating on shares of Medtronic (NYSE:MDT – Free Report) in a research report report published on Friday, Benzinga reports. They currently have a $92.00 price target on the medical technology company’s stock. Several other equities analysts also recently weighed in on MDT. Wells Fargo & Company lifted […]